Research Use Only in Australia: What the Label Means and What It Does Not
An overview of how research-use-only supply sits within Australian regulation: the TGA, the Poisons Standard, scheduling, labelling and the purchaser's responsibilities. General information, not legal advice.
“For in-vitro laboratory research only. Not for human or veterinary use.” That line appears on every vial and page we publish. This article explains what it means in the Australian context, and just as importantly, what it does not change. It is general information, not legal advice; institutions should consult their own compliance officers.
The regulators and the rules
- The Therapeutic Goods Administration (TGA) regulates therapeutic goods in Australia under the Therapeutic Goods Act 1989. Products supplied for therapeutic use generally need to be entered on the Australian Register of Therapeutic Goods (ARTG) unless an exemption applies.
- The Poisons Standard (the Standard for the Uniform Scheduling of Medicines and Poisons, SUSMP) classifies substances into schedules. Schedule 4 substances are prescription-only medicines.
- States and territories give the Poisons Standard legal effect and control the supply and possession of scheduled substances in their jurisdictions.
What “research use only” means
Research-use-only (RUO) material is supplied for laboratory investigation: in-vitro assays, analytical method development, reference standards and similar work. It is not manufactured, labelled or supplied as a medicine, and it carries none of a medicine’s quality, safety or efficacy assurances.
What the label does not do
- It does not change a substance’s schedule. If a substance is listed in Schedule 4, an RUO label does not make it unscheduled. We do not supply compounds confirmed as Schedule 4 (for example, semaglutide and tirzepatide are excluded from our catalogue and checkout entirely).
- It does not permit therapeutic claims. Copy that describes benefits in people or animals would present a product as a therapeutic good. Our compliance checks block that language from every page, including this blog.
- It does not transfer responsibility away from the purchaser. Researchers remain responsible for using material lawfully and within their institution’s approvals.
How we apply it
| Control | What it does |
|---|---|
| Research purchasing declaration | Every order records three declarations: age, research-only use and acceptance of the terms |
| Research description | Each order includes a brief description of the intended laboratory work; wording that suggests human use holds the order for review |
| Restricted-compound gate | Compounds confirmed as Schedule 4 can never be published or sold, whatever else changes |
| Copy lint | Human-use terms are blocked from product, stack and article copy before a page can be published |
| Certificates | Every lot’s analysis is published, so material can be verified against its documentation |
Other considerations for laboratories
- Anti-doping. Some compounds appear on the World Anti-Doping Agency (WADA) Prohibited List; institutions working with athletes or sports science should note this.
- Import and export. Moving research material across borders has its own requirements, separate from domestic supply.
- Institutional approvals. Biosafety and other committees may need to approve particular work.
The scheduling of individual substances can change through the TGA’s scheduling process, so check the current Poisons Standard for each compound you work with. For our full terms, see the legal and research-use pages linked in the footer.
For in-vitro laboratory research only. Not for human or veterinary use. This article summarises laboratory practice and published research. Nothing here is advice about use in people or animals.
